Phillips v ING Life Limited
[2009] FCA 283
At a glance
Source factsCourt
Federal Court of Australia
Decision date
2009-03-31
Before
Siopis J
Source
Original judgment source is linked above.
Judgment (11 paragraphs)
REASONS FOR JUDGMENT 1 In November 2002, the late Mr Gregory Peter Phillips was 50 years old. He did weight training, swam two kilometres a week and cycled 300 kms each week. His doctor described him as being as fit as an elite athlete. In that month, Mr Phillips entered into a life insurance contract with the respondent. Under the life insurance policy issued by the respondent pursuant to the contract, it agreed to pay the applicant, the late Mr Phillips's wife, the sum the $700,000 in the event that Mr Phillips died whilst the policy was in force. On 6 September 2003, whilst the policy was still in force, the late Mr Phillips died of oesophageal cancer. The applicant claimed the insured sum from the respondent. On 3 December 2003, the respondent paid the applicant the sum of $466,667. The respondent claimed that it was entitled to reduce the amount payable under the policy under s 29(4) of the Insurance Contracts Act 1984 (Cth) (the Act) because there had been nondisclosure and misrepresentation by the deceased prior to the entry into the contract of life insurance. 2 The applicant claims the sum of $233,333, being the difference between the insured sum and the sum of $466,667 paid by the respondent, and interest pursuant to s 57 of the Act.
BACKGROUND 3 In January 1997, Mr Phillips consulted his family doctor, Dr Gary Spurge, complaining of back and chest pain. After a barium meal x‑ray study of Mr Phillips yielded a suspicious result, Dr Spurge referred Mr Phillips to Dr Peter Evans, a gastroenterologist to perform a gastroscopy on Mr Phillips. 4 On 8 January 1997, Dr Evans performed the gastroscopy. Dr Evans forwarded to Dr Spurge a report of the gastroscopy. Dr Evans reported that the gastroscopy revealed that there was a large hiatus hernia and two large chronic ulcers in the oesophagus. It also revealed extensive Barrett's oesophagus. Dr Evans also reported that biopsies had been taken. The conclusion of the report stated as follows: Extensive Barrett's oesophagus with two associated ulcers. Providing biopsies benign, will need follow‑up gastroscopy in 2 months. To remain on Zoton long term. 5 Dr Evans said in evidence that Barrett's oesophagus is a change which occurs in the cells lining the oesophagus as a response to prolonged acid exposure from reflux. The main concern with this condition is the potential for malignant change. Dr Evans said that when a person had Barrett's oesophagus the demarcation between the red columnar mucosa of the stomach was further up the oesophagus than normal. He said "it looks like the lining of the stomach has crept up the oesophagus". He went on to say that "it looks like the lining of the stomach, but it has this inherent instability where it can change further and become pre‑malignant". The reason why patients with Barrett's oesophagus were required to undergo regular gastroscopies was to check for the development of premalignant change, referred to as dysplasia, in the hope of preventing any such change from becoming malignant. Dr Evans said that patients with Barrett's oesophagus as a group have a thirty‑fold increased risk of developing oesophageal cancer compared to the overall population but as an individual the actual risk of a Barrett's oesophagus patient developing oesophageal cancer is low. 6 Zoton, said Dr Evans, was a medication in tablet form which was used to treat ulcers. It reduced the acid level in the stomach fluid and served as a precaution against the development of further ulcers. The Zoton treatment referred to by Dr Evans, comprised the taking of a Zoton tablet daily. 7 On 9 January 1997, Mr Phillips consulted Dr Spurge. Dr Spurge had with him Dr Evans's report of the gastroscopy performed on Mr Phillips the previous day. Dr Spurge told Mr Phillips that he had been diagnosed as having Barrett's oesophagus. He also explained that Barrett's oesophagus was a disease of the oesophagus caused by excess exposure to gastric acid. Dr Spurge also told Mr Phillips in effect that his Barrett's oesophagus, if untreated, would be at an increased risk of turning into cancer. Dr Spurge also explained to Mr Phillips that his condition would require ongoing surveillance by way of gastroscopies. The biopsies referred to in Dr Evans's report of 8 January 1997, proved to be benign. 8 On 30 April 1997, Dr Evans performed a second gastroscopy on Mr Phillips ‑ being the gastroscopy foreshadowed in Dr Evans's report of 8 January 1997. Multiple biopsies were also taken by Dr Evans to check for dysplasia. Dr Evans again reported in writing to Dr Spurge. The conclusion of the report reads as follows: Barrett's oesophagus. Healed ulceration. To remain on Zoton long term. Providing no dysplasia on biopsies, suggest repeat gastroscopy and biopsies in 1 year. 9 The biopsies arising from the gastroscopy did not reveal dysplasia. 10 Thereafter, Mr Phillips continued to take Zoton daily and consulted Dr Spurge regularly to obtain repeat scripts for the Zoton, which Dr Spurge and Dr Evans had prescribed. 11 On 27 May 1998, Dr Evans performed a third gastroscopy and biopsies on Mr Phillips. Dr Evans's report of the gastroscopy stated as follows: Endoscopically stable Barrett's oesophagus. Suggest repeat gastroscopy in 2 years. 12 The biopsies arising from that gastroscopy proved negative. 13 On 9 November 2001, Mr Phillips consulted with Dr Spurge. At this consultation Dr Spurge referred Mr Phillips to Dr Evans for a further gastroscopy, because Mr Phillips had until then not undertaken the "repeat gastroscopy" recommended by Dr Evans in his report of 27 May 1998. 14 On 15 November 2001, Dr Evans performed a fourth gastroscopy on Mr Phillips, and biopsies were taken to check for dysplasia. Dr Evans produced a patient procedure report and sent a copy of that report to each of Dr Spurge and Mr Phillips. The conclusion of the report states: Endoscopically stable Barrett's oesophagus. Should continue with Zoton and providing biopsies negative for dysplasia check gastroscopy again in 2 years. 15 The biopsies arising from the gastroscopy proved negative. 16 During the period February 2002 to May 2002, Mr Phillips attended Dr Spurge on two occasions and obtained a repeat script for Zoton. Further, at one of the consultations, being in April 2002, Mr Phillips received a flu vaccination. At a consultation in May 2002, Dr Spurge treated Mr Phillips for a second degree burn. 17 On 3 October 2002, Mr Phillips signed an application form applying for a life insurance policy with the respondent. On the same day, Mr Phillips's adviser, Mr Paul Shepherd of the ANZ Bank, completed and sent to the respondent, an associated form stating that an appointment had been arranged for Mr Phillips to have a paramedic report prepared by "Lifescreen" on 4 October 2002. Lifescreen Australia Pty Ltd (Lifescreen) was a company which carried out health evaluations of applicants for life insurance with the respondent and prepared paramedical reports on those evaluations. 18 The first page of the application form signed by Mr Phillips contained a statement describing the applicant's duty of disclosure and stating in bold type that the duty of disclosure continued until the life insurance contract had been accepted by the respondent and confirmation was issued in writing. 19 The application form was divided into a number of sections. Three of those sections were numbered E8, E9 and E10 respectively, and headed "Personal Health Statement", "Family History" and "Health History", respectively. There was provided under each of these headings a space to answer questions relating to each of the respective topics. These three sections of the application form were prefaced with the following words contained in a box and emphasised in bold type: If a medical examination is required, or if you are completing a Paramedical Report, please go to section F on page 18. Otherwise, please complete sections E8, E9 and E10. 20 Mr Phillips did not complete those three sections of the application form. They were crossed out. 21 Section E6 of the application form was headed "Usual Doctor or Medical Centre Details" and contained a number of questions. One question asked the insurance applicant to identify his or her usual doctor. Another asked whether the insurance applicant had more than one usual doctor. Question E6(5) in that section was as follows: Please give details of your last consultations with any doctors, and if applicable, outcome or degree of recovery. (Original emphasis.) 22 The reply recorded to that question was that Mr Phillips had consulted Dr Spurge in "April" for a "flu vacination [sic]" and that there had been a "nil" outcome. 23 On 4 October 2002, Mr Phillips attended the appointment arranged with Mrs Phillipa Banks, a registered nurse, who consulted to Lifescreen. Mrs Banks had with her a form, which I will refer to as the health evaluation form. 24 On the front page of the health evaluation form there is set out a statement as to the content of the insurance applicant's duty of disclosure and the consequences of an applicant failing to comply with the duty of disclosure. The form states: DUTY OF DISCLOSURE Before you enter into a contract of life insurance with an insurer, you have a duty to disclose to the insurer every matter that you know or could reasonably be expected to know, is relevant to the insurer's decision whether to accept the risk of the insurance and, if so, on what terms. You have the duty to disclose those matters to the insurer before you extend, vary or reinstate a contract of life insurance. Your duty however, does not require disclosure of a matter: • that diminishes the risk undertaken by the insurer; • that is common knowledge; • that your insurer knows or, in the ordinary course of his business, ought to know; • disclosure of which is [waived] by the insurer. PLEASE NOTE THAT YOUR DUTY OF DISCLOSURE CONTINUES UNTIL A POLICY HAS BEEN ISSUED NON‑ DISCLOSURE If you fail to comply with your duty of disclosure and the insurer would not have entered into the contract on any terms if the failure had not occurred, the insurer may avoid the contract within 3 years of entering into it. If your non‑disclosure is fraudulent, the insurer may avoid the contract at any time. An insurer who is entitled to avoid a contract of life insurance may, within 3 years of entering into it, elect not to avoid it but to reduce the sum that you have been insured for in accordance with a formula that takes into account the premium that would have been payable if you had disclosed all relevant matters to the insurer. The insurance proposed for under this application is considered to be life insurance policies for the purpose of the Insurance Contracts Act 1984. 25 Mrs Banks did not have an independent recollection of her interview with Mr Phillips. However, in evidence, she said that it was her standard practice to tell each insurance applicant that he or she has a duty to disclose to the insurance company all the relevant facts concerning the proposed insurance. Mrs Banks said that she then would ask the insurance applicant to read the duty of disclosure statement on page one of the form and then request that the applicant sign under that statement to confirm that he or she understood the duty of disclosure before he or she answered any questions. Mr Phillips's signature appeared on the form beneath the statement containing the duty of disclosure. I accept that Mrs Banks asked Mr Phillips to read the duty of disclosure before she asked him any questions and that he did so. 26 Part D of the health evaluation form is headed: "Medical History: Life to be Insured". Relevantly for the purpose of this case, Mrs Banks deposed that her standard practice in relation to Part D of the form was as follows. Mrs Banks commenced by asking the insurance applicant the following question based on the prefatory words of that part of the health evaluation form: Have you ever experienced, required or received medical advice, investigation or treatment for any of the following and, if so what the condition is, when it first occurred, what were the symptoms, did you take any time off work and are you fully recovered. 27 Mrs Banks's practice was thereafter to read to the insurance applicant the printed words in questions D(1)‑D(25), one at a time and to write down each of the answers given by the applicant. The questions at D(22)‑D(25) apply only to female applicants. I will refer further to this aspect of Mrs Banks's practice later in these reasons. 28 The respective answers recorded in the handwriting of Mrs Banks to question D(4) and question D(19) on Mr Phillips's health evaluation form are as follows: D(4) Indigestion, ulcer, hiatus hernia, bowel disorder, Colitis, haemorrhoids or passing blood from the bowel? Swallowed a fish bone, punctured oesophagus & caused a gastric ulcer 6 yrs ago. Zoton T daily. Nil Sx past 6 yrs - Dr Spurge. D(19) Do your [sic] comtemplate [sic] seeking medical advice, undergoing any investigation or treatment or having any operation in the near future? No. 29 Mrs Banks says that in accordance with her standard practice the answer would have reflected the answer which Mr Phillips had given to her when she had asked the question of him during the interview. I accept this to be the case. 30 Mrs Banks said that her standard practice was that after completing the form, she invited the insurance applicant to read it to satisfy himself or herself that the information provided was correct. Then she asked the applicant to sign on the last page of the form. Mr Phillips signed the last page of the form. I accept that Mrs Banks acted in accordance with her standard practice in this respect. 31 It was accepted that the ulcers that Mr Phillips had contracted in January 1997 were not caused by him swallowing a fish bone, nor were they gastric ulcers. However, the respondent did not rely upon the inaccuracy of these statements. 32 Each of the completed forms in respect of Mr Phillips, was submitted to the respondent. In November 2002, Mr Anthony Webb, the State Underwriting Manager of the respondent in Western Australia perused the application form and health evaluation form submitted in respect of Mr Phillips. Mr Webb required some further inquiries to be made regarding Mr Phillips's occupation and his participation in competitive cycling to which Mr Phillips had referred in the application form. On 18 November 2002, Mr Webb signed an internal assessment memorandum agreeing to the proposal for life insurance submitted by Mr Phillips. On 19 November 2002, the respondent issued to Mr Phillips a life insurance policy pursuant to which it agreed to pay the applicant, as the nominated beneficiary, $700,000 in the event of the death of Mr Phillips, during the currency of the policy. 33 On 17 February 2003, Mr Phillips consulted with Dr Spurge and advised Dr Spurge that he was experiencing some pain when drinking. Dr Spurge changed Mr Phillips's treatment from Zoton to Nexium. 34 On 4 April 2003, Mr Phillips presented to Dr Spurge with a feeling of obstruction in the throat and Mr Phillips said that he was getting pain with drinking water and with eating. Dr Spurge referred Mr Phillips to Dr Evans for a gastroscopy. On 8 April 2003, Dr Evans performed a gastroscopy on Mr Phillips and determined that he had a malignant oesophageal ulcer. The malignant ulcer appears to have been contiguous to, but not located within, the tissue affected by Mr Phillips's Barrett's oesophagus. 35 On 6 September 2003, Mr Phillips died of oesophageal cancer. 36 On 18 September 2003, the applicant forwarded to the respondent a life insurance claim form under the policy. 37 By a letter dated 3 December 2003 addressed to the applicant, the respondent advised that prior to the issue of the life insurance policy, Mr Phillips had failed to disclose that he had Barrett's oesophagus and that he had undergone consultations and "endoscopies" and that had those disclosures been made, the underwriters would have "offered a loading of +50% for life insurance". The letter went on to state that pursuant to s 29(4) of the Act, "we have reduced the sum insured in proportion that the premium paid bears to the premium that should have been paid".